Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
Universitat Autònoma de Barcelona · Red Espanola de Investigacion en Patologia Infecciosa · +4 more institutions
Abstract
, especially strains with certain specific mechanisms of resistance. A section is devoted to reviewing upcoming active drugs such as imipenem-relebactam, cefepime-zidebactam, cefiderocol, and murepavadin. Finally, other therapeutic strategies, such as use of vaccines, antibodies, bacteriocins, anti-quorum sensing, and bacteriophages, are described as future options.
Citation impact
- FWCI
- 26.09
- Percentile
- 100%
- References
- 365
Authors
8- JPJuan Pablo HorcajadaCorresponding
Universitat Autònoma de Barcelona, Red Espanola de Investigacion en Patologia Infecciosa, Hospital del Mar Research Institute
- MMM. Montero
Universitat Autònoma de Barcelona, Red Espanola de Investigacion en Patologia Infecciosa, Hospital del Mar Research Institute
- AOAntonio Oliver
Health Research Institute of the Balearic Islands
- LSLuisa Sorlí
Universitat Pompeu Fabra, Red Espanola de Investigacion en Patologia Infecciosa, Hospital del Mar Research Institute
- SLSònia Luque
Universitat Autònoma de Barcelona, Hospital del Mar Research Institute
Topics & keywords
- Pseudomonas aeruginosa
- Epidemiology
- Multiple drug resistance
- Drug resistance
- Medicine
- Drug
- In vivo
- Pharmacology
- Good health and well-being